nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSK—periosteum—cleft lip	0.11	0.208	CbGeAlD
Boceprevir—CTSK—skull—cleft lip	0.0903	0.171	CbGeAlD
Boceprevir—CTSK—cartilage tissue—cleft lip	0.077	0.146	CbGeAlD
Boceprevir—CTSL—mouth—cleft lip	0.0415	0.0785	CbGeAlD
Boceprevir—CTSK—mouth—cleft lip	0.0313	0.0591	CbGeAlD
Boceprevir—CTSL—embryo—cleft lip	0.0296	0.0559	CbGeAlD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—IRF6—cleft lip	0.0287	0.0609	CbGpPWpGaD
Boceprevir—CTSS—mouth—cleft lip	0.0274	0.0518	CbGeAlD
Boceprevir—CTSL—telencephalon—cleft lip	0.0241	0.0455	CbGeAlD
Boceprevir—CTSS—embryo—cleft lip	0.0195	0.0369	CbGeAlD
Boceprevir—CTSV—head—cleft lip	0.0183	0.0347	CbGeAlD
Boceprevir—CMA1—ACE Inhibitor Pathway—NOS3—cleft lip	0.0177	0.0375	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—PTCH1—cleft lip	0.0164	0.0348	CbGpPWpGaD
Boceprevir—CTSS—telencephalon—cleft lip	0.0159	0.03	CbGeAlD
Boceprevir—CTSL—head—cleft lip	0.015	0.0283	CbGeAlD
Boceprevir—CTSK—head—cleft lip	0.0113	0.0213	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—TGFB3—cleft lip	0.0102	0.0216	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB3—cleft lip	0.0102	0.0216	CbGpPWpGaD
Boceprevir—CTSS—head—cleft lip	0.00989	0.0187	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—FGF7—cleft lip	0.00977	0.0207	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB3—cleft lip	0.00944	0.02	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—FGFR1—cleft lip	0.00914	0.0194	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGF8—cleft lip	0.00902	0.0191	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—FGFR3—cleft lip	0.00864	0.0183	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—BHMT2—cleft lip	0.00861	0.0183	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB3—cleft lip	0.00841	0.0179	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGF3—cleft lip	0.00734	0.0156	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGF9—cleft lip	0.00716	0.0152	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB3—cleft lip	0.00693	0.0147	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—FGF2—cleft lip	0.00667	0.0142	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—NANS—cleft lip	0.00619	0.0131	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGF10—cleft lip	0.00604	0.0128	CbGpPWpGaD
Boceprevir—ABCB1—ABC-family proteins mediated transport—ABCA4—cleft lip	0.00598	0.0127	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—BMP4—cleft lip	0.00567	0.012	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—BMP4—cleft lip	0.00567	0.012	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—BMP4—cleft lip	0.00527	0.0112	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGFR2—cleft lip	0.00484	0.0103	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—BMP4—cleft lip	0.0047	0.00998	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGFR1—cleft lip	0.00452	0.00959	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGFR3—cleft lip	0.00427	0.00906	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ARHGAP29—cleft lip	0.00414	0.00879	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—BMP4—cleft lip	0.00387	0.00822	CbGpPWpGaD
Boceprevir—ABCB1—embryo—cleft lip	0.00345	0.00651	CbGeAlD
Boceprevir—CTSV—Innate Immune System—FGF7—cleft lip	0.0034	0.00723	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF7—cleft lip	0.0034	0.00723	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—FGF2—cleft lip	0.0033	0.007	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF7—cleft lip	0.00327	0.00694	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF7—cleft lip	0.00327	0.00694	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IRF6—cleft lip	0.00316	0.00672	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IRF6—cleft lip	0.00316	0.00672	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF8—cleft lip	0.00314	0.00667	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGF8—cleft lip	0.00314	0.00667	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—SUMO1—cleft lip	0.00302	0.00642	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF8—cleft lip	0.00302	0.0064	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF8—cleft lip	0.00302	0.0064	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGF7—cleft lip	0.00282	0.00599	CbGpPWpGaD
Boceprevir—ABCB1—telencephalon—cleft lip	0.0028	0.0053	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—FGF7—cleft lip	0.00271	0.00575	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IRF6—cleft lip	0.00262	0.00556	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGF8—cleft lip	0.0026	0.00553	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF3—cleft lip	0.00256	0.00543	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGF3—cleft lip	0.00256	0.00543	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGF8—cleft lip	0.0025	0.00531	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGF9—cleft lip	0.00249	0.00529	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF9—cleft lip	0.00249	0.00529	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF3—cleft lip	0.00246	0.00521	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF3—cleft lip	0.00246	0.00521	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF9—cleft lip	0.00239	0.00508	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF9—cleft lip	0.00239	0.00508	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF7—cleft lip	0.00232	0.00493	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—WNT9B—cleft lip	0.00227	0.00482	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF7—cleft lip	0.00223	0.00474	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOG—cleft lip	0.00218	0.00462	CbGpPWpGaD
Boceprevir—CTSL—Immune System—SUMO1—cleft lip	0.00217	0.0046	CbGpPWpGaD
Boceprevir—CTSV—Immune System—SUMO1—cleft lip	0.00217	0.0046	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IRF6—cleft lip	0.00216	0.00458	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—FGF2—cleft lip	0.00215	0.00456	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—FGF2—cleft lip	0.00215	0.00456	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF8—cleft lip	0.00214	0.00455	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGF3—cleft lip	0.00212	0.0045	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGF10—cleft lip	0.0021	0.00447	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF10—cleft lip	0.0021	0.00447	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGF9—cleft lip	0.00207	0.00439	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF8—cleft lip	0.00206	0.00437	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGF3—cleft lip	0.00204	0.00432	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ABCA4—cleft lip	0.00202	0.00429	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF10—cleft lip	0.00202	0.00429	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF10—cleft lip	0.00202	0.00429	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—FGF2—cleft lip	0.002	0.00424	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGF9—cleft lip	0.00198	0.00421	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF7—cleft lip	0.00198	0.00421	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF7—cleft lip	0.00198	0.00421	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF8—cleft lip	0.00183	0.00388	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF8—cleft lip	0.00183	0.00388	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—WNT3—cleft lip	0.0018	0.00383	CbGpPWpGaD
Boceprevir—CTSK—Immune System—SUMO1—cleft lip	0.0018	0.00381	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—FGF2—cleft lip	0.00178	0.00378	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF3—cleft lip	0.00175	0.0037	CbGpPWpGaD
Boceprevir—ABCB1—head—cleft lip	0.00174	0.0033	CbGeAlD
Boceprevir—CTSK—Innate Immune System—FGF10—cleft lip	0.00174	0.0037	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF9—cleft lip	0.0017	0.00361	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGFR2—cleft lip	0.00169	0.00358	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGFR2—cleft lip	0.00169	0.00358	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF3—cleft lip	0.00168	0.00356	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGF10—cleft lip	0.00167	0.00355	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF7—cleft lip	0.00164	0.00349	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF9—cleft lip	0.00163	0.00347	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGFR2—cleft lip	0.00162	0.00344	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGFR2—cleft lip	0.00162	0.00344	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGFR1—cleft lip	0.00157	0.00334	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGFR1—cleft lip	0.00157	0.00334	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF8—cleft lip	0.00152	0.00322	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGFR1—cleft lip	0.00151	0.00321	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGFR1—cleft lip	0.00151	0.00321	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF3—cleft lip	0.00149	0.00316	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF3—cleft lip	0.00149	0.00316	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGFR3—cleft lip	0.00149	0.00316	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGFR3—cleft lip	0.00149	0.00316	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SUMO1—cleft lip	0.00148	0.00314	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—FGF2—cleft lip	0.00147	0.00311	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF9—cleft lip	0.00145	0.00308	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF9—cleft lip	0.00145	0.00308	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF10—cleft lip	0.00144	0.00305	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGFR3—cleft lip	0.00143	0.00303	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGFR3—cleft lip	0.00143	0.00303	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGFR2—cleft lip	0.0014	0.00297	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF10—cleft lip	0.00138	0.00293	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF7—cleft lip	0.00135	0.00287	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGFR2—cleft lip	0.00134	0.00285	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGFR1—cleft lip	0.0013	0.00277	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGFR1—cleft lip	0.00125	0.00266	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF8—cleft lip	0.00125	0.00265	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF3—cleft lip	0.00123	0.00262	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGFR3—cleft lip	0.00123	0.00262	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF10—cleft lip	0.00123	0.0026	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF10—cleft lip	0.00123	0.0026	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF9—cleft lip	0.0012	0.00255	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00119	0.00253	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF7—cleft lip	0.00119	0.00253	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SPRY2—cleft lip	0.00119	0.00253	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—MTR—cleft lip	0.00119	0.00253	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGFR3—cleft lip	0.00118	0.00251	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGFR2—cleft lip	0.00115	0.00245	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—FGF2—cleft lip	0.00115	0.00244	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—FGF2—cleft lip	0.00115	0.00244	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGFR2—cleft lip	0.00111	0.00235	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—FGF2—cleft lip	0.0011	0.00234	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—FGF2—cleft lip	0.0011	0.00234	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF8—cleft lip	0.0011	0.00234	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGFR1—cleft lip	0.00107	0.00228	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGFR1—cleft lip	0.00103	0.00219	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF3—cleft lip	0.00102	0.00216	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF10—cleft lip	0.00102	0.00215	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGFR3—cleft lip	0.00101	0.00215	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF9—cleft lip	0.000991	0.0021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTCH1—cleft lip	0.000988	0.0021	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGFR2—cleft lip	0.000983	0.00209	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGFR2—cleft lip	0.000983	0.00209	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGFR3—cleft lip	0.000974	0.00207	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—FGF2—cleft lip	0.000952	0.00202	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGFR1—cleft lip	0.000916	0.00195	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGFR1—cleft lip	0.000916	0.00195	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—FGF2—cleft lip	0.000914	0.00194	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF3—cleft lip	0.000895	0.0019	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF9—cleft lip	0.000873	0.00185	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGFR3—cleft lip	0.000866	0.00184	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGFR3—cleft lip	0.000866	0.00184	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF10—cleft lip	0.000836	0.00177	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGFR2—cleft lip	0.000815	0.00173	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—FGF2—cleft lip	0.000784	0.00166	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGFR1—cleft lip	0.000759	0.00161	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—FGF2—cleft lip	0.000753	0.0016	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF10—cleft lip	0.000736	0.00156	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGFR3—cleft lip	0.000718	0.00152	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGFR2—cleft lip	0.000671	0.00142	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGF2—cleft lip	0.000669	0.00142	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGF2—cleft lip	0.000669	0.00142	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGFR1—cleft lip	0.000625	0.00133	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.000625	0.00133	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.000608	0.00129	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGFR3—cleft lip	0.000591	0.00125	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR2—cleft lip	0.000591	0.00125	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FGF2—cleft lip	0.000555	0.00118	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—MTR—cleft lip	0.000554	0.00118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR1—cleft lip	0.000551	0.00117	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR3—cleft lip	0.000521	0.00111	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.000507	0.00108	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF2—cleft lip	0.000457	0.000969	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.000429	0.00091	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF2—cleft lip	0.000402	0.000854	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOS3—cleft lip	0.000397	0.000842	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC19A1—cleft lip	0.000355	0.000753	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000313	0.000664	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TCN2—cleft lip	0.000294	0.000624	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC19A1—cleft lip	0.000268	0.000568	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—cleft lip	0.000263	0.000558	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TCN2—cleft lip	0.000222	0.000471	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000205	0.000434	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTR—cleft lip	0.000204	0.000432	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000165	0.00035	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTR—cleft lip	0.000154	0.000326	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TCN2—cleft lip	0.000137	0.00029	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—cleft lip	0.000125	0.000265	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—cleft lip	0.000109	0.000232	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTR—cleft lip	9.47e-05	0.000201	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—cleft lip	9.42e-05	0.0002	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—cleft lip	8.23e-05	0.000175	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—cleft lip	7.61e-05	0.000161	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—cleft lip	5.8e-05	0.000123	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—cleft lip	5.74e-05	0.000122	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—cleft lip	5.07e-05	0.000108	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—cleft lip	3.54e-05	7.51e-05	CbGpPWpGaD
